Kumar Visvanathan

Validation of a novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study

Jessica Howell, Huy Van, Minh D Pham, Rohit Sawhney, Fan Li, Purnima Bhat, John Lubel, William Kemp, Stephen Bloom, Avik Majumdar, Geoffrey W McCaughan, Samuel Hall, Timothy Spelman, Joseph S Doyle, Margaret Hellard, Kumar Visvanathan, Alexander Thompson, Heidi E Drummer, David Anderson

Journal article  |  2023  |  LIVER INTERNATIONAL

BACKGROUND: Alanine aminotransferase (ALT) measurement is essential for evaluation of liver disease. We validated a novel rapid po..

Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern

Steven Y Gao, Nancy B Amaro-Mugridge, Jocelyn Madrid-Weiss, Nikolina Petkovic, Natasha Vanegas, Kumar Visvanathan, Bryan RG Williams, Jennifer A MacDiarmid, Himanshu Brahmbhatt

Journal article  |  2023  |  FRONTIERS IN IMMUNOLOGY

Most current anti-viral vaccines elicit a humoral and cellular immune response via the pathway of phagocytic cell mediated viral a..

Diabetes IN hospital - Glucose and Outcomes in the COVID-19 pandemic (DINGO COVID-19): the 2020 Melbourne hospital experience prior to novel variants and vaccinations

Rahul D Barmanray, Joanna Y Gong, Mervyn Kyi, Dev Kevat, Mohammad A Islam, Anna Galligan, Georgina R Manos, Indu Nair, Nayomi Perera, Nicholas K Adams, Ashvin Nursing, Annabelle M Warren, Peter S Hamblin, Richard J MacIsaac, Elif Ekinci, Balasubramanian Krishnamurthy, Harin Karunajeewa, Kirsty Buising, Kumar Visvanathan, Thomas WH Kay, et al.

Journal article  |  2022  |  INTERNAL MEDICINE JOURNAL

BACKGROUND AND AIMS: A relationship between diabetes, glucose and COVID-19 outcomes has been reported in international cohorts. Th..

Validation of novel point-of-care test for alanine aminotransferase measurement: A pilot cohort study.

Jessica Howell, Huy Van, Minh Pham, Rohit Sawhney, Fan Li, Purnima Bhat, John Lubel, William Kemp, Stephen Bloom, Avik Majumdar, Geoff McCaughan, Samuel Hall, Timothy Spelman, Joseph S Doyle, Margaret Hellard, Kumar Visvanathan, Alexander J Thompson, Heidi E Drummer, David Anderson

Journal article  |  2022  |  Clin Liver Dis (Hoboken)

Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways

Samuel Al Hall, Gareth S Burns, Benjamin J Mooney, Rosemary Millen, Rachel Morris, Sara Vogrin, Vijaya Sundararajan, Dilip Ratnam, Miriam T Levy, John S Lubel, Amanda J Nicoll, Simone Strasser, William Sievert, Paul Desmond, Meng C Ngu, Peter Angus, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A Revill, et al.

Journal article  |  2022  |  JOURNAL OF INFECTIOUS DISEASES

BACKGROUND: We evaluated the patterns of peripheral Toll-like receptor (TLR) signaling activity and the expression of TLRs and nat..

Assessment of the cobas (R) HBV RNA investigational assay in the setting of nucleoside analog therapy cessation

Kathy Jackson, Sara Bonanzinga, Ros Edwards, Kumar Visvanathan, Xin Li, Samuel Hall, Alison Kuchta, Jesse A Canchola, Alex J Thompson

Journal article  |  2022  |  JOURNAL OF MEDICAL VIROLOGY

HBV RNA is used as a marker of cccDNA transcription and is applicable in the setting of nucleos(t)ide analog (NA) treatment, which..

Serum HBV RNA levels are associated with risk of hepatitis flare after stopping NA therapy in HBeAg-negative patients

Kathy Jackson, Kumar Visvanathan, Samuel Hall, Gareth Burns, Sara Bonanzinga, Despina Anagnostou, Paul Desmond, Dilip Ratnam, William Sievert, Miriam Levy, Amanda Nicoll, John Lubel, Peter Angus, Marie Sinclair, Simone Strasser, Meng Ngu, Christopher Meredith, Gail Matthews, Peter Revill, Vijaya Sundararajan, et al.

Conference Proceedings  |  2022  |  JOURNAL OF HEPATOLOGY

Stable rates of cirrhosis diagnosed by Fibroscan despite changing trends in liver disease epidemiology: a single centre retrospective cohort study

Joan Ericka Flores, Anne Craigie, Lucy McDonald, Amy Edwards, Tim Papaluca, Michael MacIsaac, John Gough, Kate New, Susanne Glasgow, Bradley Whitton, Paul Desmond, Marno Ryan, Thai Hong, Zina Valaydon, Jacinta Holmes, Barbara Demediuk, Catherine Croagh, David Iser, Kumar Visvanathan, Swee Lin Chen Yi Mei, et al.

Journal article  |  2022  |  JOURNAL OF HEPATOLOGY

Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels

Samuel AL Hall, Gareth S Burns, Despina Anagnostou, Sara Vogrin, Vijaya Sundararajan, Dilip Ratnam, Miriam T Levy, John S Lubel, Amanda J Nicoll, Simone Strasser, William Sievert, Paul Desmond, Meng C Ngu, Peter Angus, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A Revill, Kathy Jackson, Margaret Littlejohn, et al.

Journal article  |  2022  |  ALIMENTARY PHARMACOLOGY & THERAPEUTICS

BACKGROUND AND AIMS: Current guidelines recommend long-term nucleot(s)ide analogue (NA) therapy for patients with HBeAg-negative c..

EP1292: MONOCYTE DISTRIBUTION WIDTH IS ASSOCIATED WITH INFLIXIMAB RESPONSE IN ACUTE SEVERE ULCERATIVE COLITIS

Christopher Li Wai Suen, Matthew Choy, Joanne Wiid, Kristy Boyd, Raquel Pena, Kathryn Burrell, Kumar Visvanathan, Peter De Cruz

Journal article  |  2022  |  Gastroenterology